Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MD › Baltimore › NPI 1679618359
Physician

ST Paul Place Specialists, INC.

ST Paul Place Specialists, INC. was paid $949K by Medicaid between Mar 2018 and Apr 2023, across 21 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 66% of everything it billed.

33Billing provider infoST PAUL PLACE SPECIALISTS, INC.
BALTIMORE, MD 21202
33aNPI1679618359assigned 02/21/2007
28Total paid$949K
24GClaims21,716
24DCodes billed21
24AFirst – last monthMar 2018 – Apr 2023

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official DEIBEL, JUSTIN controls 19+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018200$2K
201968$504.98
20205,947$328K
20219,072$465K
20225,681$153K
2023748$51.33
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 66% 8,559 7,391 $630K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 15% 1,525 1,294 $143K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 15% 3,263 2,855 $138K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2.0% 4,301 3,657 $19K
80053 Comprehensive metabolic panel <1% 1,487 1,222 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,261 1,040 $5K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 14 13 $1K
84443 Thyroid stimulating hormone (TSH) <1% 237 175 $1K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 35 34 $895.48
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 35 34 $895.48
80061 Lipid panel <1% 242 190 $833.89
83735 <1% 253 155 $756.68
9 more codes
86780 <1% 83 $691.51
83036 Hemoglobin; glycosylated (A1C) <1% 181 $431.40
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 33 $392.70
87581 <1% 14 $305.55
83540 <1% 77 $243.84
84439 <1% 44 $230.27
83550 <1% 20 $82.28
82248 <1% 26 $26.82
82247 <1% 26 $26.82

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialDEIBEL, JUSTIN (VICE CHAIR)
Same official

Other billing entities under DEIBEL, JUSTIN

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.